Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells-Reference-Cited by-同舟云学术

Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells

Published:2011-09-14 Issue:12 Volume:86 Page:967-973
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Katodritou Eirini,Terpos Evangelos,North Janet,Kottaridis Panagiotis,Verrou Evgenia,Gastari Vasiliki,Chadjiaggelidou Christina,Sivakumaran Shivajanani,Jide-Banwo Samuel,Tsirogianni Maria,Kapetanos Dimitrios,Zervas Konstantinos,Lowdell Mark W.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.22163/fullpdf

Reference32 articles.

1. Multiple myeloma;Kyle;N Eng J Med,2004

2. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): An analysis of the Greek Myeloma Study Group (GMSG);Kastritis;Leukemia,2009

3. Management of multiple myeloma: The changing landscape;Reece;Blood Rev,2007

4. Progress in hematopoietic stem cell transplantation in multiple myeloma;Gahrton;Curr Opin Hematol,2005

5. Immunosuppressive networks in the tumour environment and their therapeutic relevance;Zou;Nat Rev Cancer,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2024-07

2. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08

3. Characterization of human natural killer cells for therapeutic use;Cytotherapy;2019-03

4. Direct RIG‐I activation in human NK cells induces TRAIL‐dependent cytotoxicity toward autologous melanoma cells;International Journal of Cancer;2019-01-09

5. Translating the anti-myeloma activity of Natural Killer cells into clinical application;Cancer Treatment Reviews;2018-11